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Abstract
Background: To identify objective and subjective indicators of death in prevalent hemodialysis (HD) patients in a
follow-up study of 12 months.
Methods: The study included end-stage renal disease patients undergoing HD and analyzed demographic and
laboratory data from the dialysis unit’s records. Baseline data concerning socioeconomic status, comorbidity, quality
of life level, coping style and depression were also assessed. For variables that differed in the comparison between
survivors and non-survivors, Cox proportional hazards for death were calculated.
Results: The mortality rate was 13.0%. Non-survivors differed in age, comorbidity, inclusion on the transplant
waiting list and physical functioning score. The hazard ratios of death were 8.958 (2.843-28.223; p < 0.001) for
comorbidity, 3.992 (1.462-10.902; p = 0.007) for not being on the transplant waiting list, 1.038 (1.012-1.066; p =
0.005) for age, and 0.980 (0.964-0.996; p = 0.014) for physical functioning.
Conclusions: Comorbidity, not being on the transplant waiting list, age and physical functioning, which reflects
physical status, must be seen as risk indicators of death among patients undergoing HD.
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Background
Fifty years ago the introduction of the Scribner shunt
allowed the realization of repeated hemodialysis (HD)
sessions [1]. This advance greatly extended the survival
of patients suffering from end-stage renal disease
(ESRD). Today there are some 80,000 ESRD patients
undergoing HD in Brazil [2]. But the efficiency of dialy-
sis treatment is limited. HD does not perform all normal
kidney functions, and patients under HD retain several
molecules, provoking uremic toxicity, oxidative stress
and chronic inflammation [3]. The main consequence is
high mortality. Mortality rates vary among HD patients
throughout the world. It is low in Japan (6.6%), inter-
mediate in Europe (15.6%) and Brazil (17.0%), and high
in the United States (21.7%) [2,4]. Demographic and
clinical characteristics, access to kidney transplantation
and practice patterns explain the mortality differences.
Age seems to be a good indicator of risk of death. In
the Brazilian population, crude mortality is different
according to age ranges, being 8.3% in the range
between 20 and 39 years old and 59.0% among patients
above 60 [2]. Directly linked to age is comorbidity. Age
and the most common ESRD etiologies, namely hyper-
tension and diabetes, lead to multiple organ dysfunc-
tions, mainly cardiovascular. However, samples of HD
patients are not homogeneous. Roughly speaking, in
underdeveloped areas the profile is younger patients
with low comorbidity, with the principal etiology being
glomerulonephritis rather than diabetes. In contrast, in
developed areas there is prevalence of older and diabetic
patients. Based on data showing a higher risk of death
in earlier stages of chronic kidney disease than after
reaching advanced stages and the requirements for dia-
lysis [5], we can hypothesize that the main attention on
infectious diseases in underdeveloped areas relegates
medical assistance to patients with chronic diseases to
secondary importance. Probably diabetics in
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assistance tend to die more than in developed areas
before developing ESRD. Also, in underdeveloped areas
life expectancy is lower, thus decreasing the emergence
of diabetes.
Sobral is a city located in the semiarid region of
northeast Brazil. Our unit in Santa Casa Hospital is the
only renal unit within a radius of 200 km. We serve a
region of 1,800,000 inhabitants. As stated previously,
due to the sample characteristics, mortality rates and
predictors can vary. Virtually all our patients have low
socioeconomic status [6]. Such patients need more
social support to undergo dialysis. In Sobral, we provide
living quarters and meals during the periodic dialysis
sessions.
Most studies in Brazil are performed in more devel-
oped areas of the country, where the leading universities
are located. The patient profile and mortality risk differ
widely in the various regions of Brazil, depending on
socioeconomic and demographic characteristics of the
sample. Mortality indicators are mainly objective, like
age, comorbibity and albumin level. However, quality of
life has been increasingly recognized as an independent
indicator of mortality [7]. So, the aim of this study is to
identify objective and subjective indicators of death in
prevalent HD patients from a renal dialysis unit located
in a low-income area in a 12-month follow-up study.
Methods
Sample
The sample included ESRD patients undergoing HD
during April 2009 in the only renal unit in northern
Ceará state, northeast Brazil. The criteria for inclusion
were age older than 18, at least three months on dialysis
and no previous transplantation. Out of 191 patients
being treated by the unit that month, 161 were included.
The reasons for exclusion were: 14 with less than three
months on therapy, 8 with previous transplants, 5 refu-
sals and 3 under 18 years old. All patients were under-
going conventional HD with polysulfone dialyzers
(maximum number of reuses = 12). The study protocol
and informed consent form were approved by the ethics
committee of Vale do Acaraú University, which is the
only ethics committee in our region.
Measurement of quality of life
The measurement tool was the validated Brazilian ver-
sion of the Medical Outcomes Study 36-Item Short
Form Health Questionnaire (SF-36) [8]. The question-
naire was applied through interviews during April 2009,
conducted by three professionals who did not belong to
the dialysis unit team. This is a well-validated 36-item
questionnaire covering issues relating to physical, psy-
chological and social functioning. It generates scores
from 0 (worst) to 100 (best) for eight sub-scales of qual-
ity of life: physical functioning, role-physical, bodily
pain, general health, vitality, social functioning, role-
emotional and mental health.
Coping
The first version of the Jalowiec Coping Scale [9] was
used, adapted to Portuguese by Souza-Talarico and col-
leagues [10], which consists of 40 items to determine
coping style. This is a well-validated instrument, based
on the cognitive theory of psychological stress and cop-
ing proposed by Lazarus and Folkman [11]. The 40
items are grouped into two styles: problem-oriented
coping, comprising 15 items (scores ranging from 15 to
75), and emotion-oriented coping, comprising 25 items
(scores ranging from 25 to 125). Problem-oriented cop-
ing aims to make direct changes in a stressful situation,
whereas emotion-oriented coping seeks to ameliorate
emotions associated with the problem. Subjects are eval-
uated about coping styles according to a five-point
Likert scale, ranging from “never do” to “always do”.
Depression
For this analysis, the 10-item version of the Center for
Epidemiologic Studies Depression Scale [12] was used.
Respondents rate items by recalling the past week and
using a three-point response scale, with higher scores
indicating the presence and persistence of symptoms. A
score ranging from 0 to 30 is calculated by summing
the score of each item. A score ≥ 10 is classified as
depression.
Patient data
The demographic data, time on dialysis, inclusion on
transplant waiting list and underlying etiology of ESRD
were obtained from dialysis unit records. The underlying
kidney disease was classified by clinical criteria and not
by histopathology. Classification of socioeconomic status
was according to criteria of the form issued by the Bra-
zilian Association of Research Institutes [13]. This vali-
d a t e di n s t r u m e n ti su s e di nm a r k e t i n gs u r v e y sa n d
population censuses and grades socioeconomic status
into five subgroups: A (best status) through E (worst
status). Besides income level, its criteria include educa-
tional level of the head of household and ownership of
household appliances. Each patient was assigned a low,
medium or high risk index based on comorbidity, as
described by Khan et al. [14]. Khan’s comorbidity index
takes into consideration age in three classes and nine
comorbidities: diabetes, myocardial infarction, angina
pectoris, congestive heart failure, liver cirrhosis, obstruc-
tive pulmonary disease, systemic collagen disease, pul-
monary fibrosis and visceral malignancies. The
laboratory results were those routinely measured in HD
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phosphorus and Kt/V. Kt/V was estimated using a sec-
ond-generation Daugirdas formula [15].
The instruments SF-36, Jalowiec Coping Scale and the
Center for Epidemiologic Studies Depression Scale were
applied on the day of the patient’s regular hemodialysis,
before the dialysis session, in a private office by an inter-
viewer who was not a renal unit staff member. After
gathering the baseline data, we obtained data from the
patients’ medical records on death in the next 12
months (April 2009 through March 2010).
Statistical analyses
Comparisons between survivors and non-survivors were
performed by the Fisher and Student’s t tests, after
using the Shapiro-Wilk test to verify if the data were
normally distributed. Cox proportional hazards were cal-
culated to measure the risk of death according to the
variables that differed in the comparison between survi-
vors and non-survivors. Censoring occurred at the end
of one year of follow-up or renal transplantation. There
was no other kind of loss besides transplantation.
Results
More than 70% of the patients were classified as per-
taining to the lowest socioeconomic classes (D and E).
Moreover, the majority of them had low comorbidity,
and based on mean laboratory values, they presented a
good level of albumin (which is an indicator of nutri-
tional and inflammatory status). They also had good
control of calcium-phosphorus product (levels above 55
mg
2/dl
2 increase mortality risk) and were submitted to
an adequate dialysis dose, as estimated by the Kt/V
index (target > 1.2). Nevertheless, the control of anemia
was far from the ideal (mean hemoglobin of the sample
was 8.5 ± 1.7 g/dl versus the recommended target of 11
to 12 g/dl). (Table 1)
The most affected dimensions of QOL were role-phy-
sical and general health, and the best-scored dimensions
were social functioning and bodily pain. There were 8%
of depressed patients. From a possible maximum score
of 75 related to problem-oriented coping, the mean
score was 51.3 ± 8.4, and from a possible maximum
score of 125 related to emotion-oriented coping, the
mean score was 68.2 ± 9.7, showing a slight trend to
more common use of problem-oriented coping. (Table
2)
The mortality rate was 13.0%. Patients who died were
older (53.6 ± 11.9 vs. 43.1 ± 15.7 years; p = 0.002), had
higher comorbidity (19.0% vs. 2.1%; p = 0.002), were less
often on the transplant waiting list (23.8% vs. 57.1%, p =
0.005), needed more hospitalization (57.1% vs. 7.1%; p <
0.001) and presented lower physical functioning scores
(42.6 ± 26.3 vs. 57.6 ± 24.9; p =0 . 0 2 3 ) .T h e
comparisons of the characteristics between survivors
and non-survivors are shown in Tables 1 and 2.
Table 3 shows the hazard ratios of death according to
each variable that differed between survivors and non-
survivors.
Discussion
As previously stated, our sample is characteristic of an
underdeveloped area, comprising young patients (mean
age of 44.5 years) and few diabetics-only 9.9% of the
sample. Our main interest was to test if emerging sub-
jective measures, like quality of life, depression and cop-
ing, were able to predict death in a small sample like
ours. But we found that traditional objective variables,
mostly reflecting physical status, were the only indica-
tors of death.
Measures of subjective feelings are validated as prog-
nostic markers among HD patients [16-19]. But none of
the subjective measures obtained from the sample corre-
lated with risk of death, except one dimension of quality
of life. However, this dimension correlated with risk of
death was physical functioning, which is typically related
to physical status. Its score is generated from questions
about daily activities that become difficult because of
the patient’s poor health. Thus, physical functioning
assessed by SF-36 seems to reflect physical status more
than subjective feelings.
Overall, we found that the main difference between
survivors and non-survivors can be summarized by phy-
sical status, assessed in our study by different variables.
The question of colinearity between these variables
must be emphasized. Age, comorbidity grade, not being
in the transplant waiting list, and physical functioning,
as assessed by SF-36, all summarize a single clinical con-
d i t i o n :p h y s i c a ls t a t u s .A g e ,c o m o r b i d i t ya n dp h y s i c a l
functioning can be easily identified as correlated with
physical status. Also, not being on the waiting transplant
list reflects physical status due the fact that the main
reasons for not being on the list are physical aspects
linked to organ dysfunction.
Our results indicate that assessment of physical status
is a valid way to stratify risk of death among HD
patients even in small unicentric samples. Fortunately,
physical status can be assessed in many easy ways, such
as use of routine variables present in renal units’
records, like age and not being on the transplant waiting
list, and also through application of validated instru-
ments. There are several kinds of instruments for clini-
cal use to assess physical status which were extensively
used in dialysis studies: (i) quality of life measurements:
all generic instruments to measure quality of life cover
physical status through questions about ability to per-
form daily living activities; (ii) comorbidity indices: the
fact that HD patients suffer from several organ
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the field of nephrology to use comorbidity indices, like
those of Khan, Davies and Charlson [20]; (iii) specific
instruments related to renal disease severity: the use of
the end-stage renal disease severity index (ESRD-SI) is
another way of assessing physical status [21]; and (iv)
the Karnofsky scale: the pioneer instrument on func-
tional status is still useful [22].
T h er o l eo fs u b j e c t i v em e a s u r e sm u s tb er e m e m -
bered, even in a discussion about mortality, in which
subjective measures did not predict death. First, in a
scenario of high mortality, knowledge of how patients
perceive their lives is a main outcome along with sur-
vival. Second, subjective feelings are influenced by
cultural and socioeconomic status and for this reason
there can be distinct patterns of samples. This point
was the basis of our hypothesis that specific predictors
of death among samples from low-income areas could
be quite different from developed areas, a hypothesis
not confirmed by our results. Only traditional and
objective prognostic markers related to physical condi-
tion were identified.
The fact of only covering prevalent patients, hence
including patients in different stages of disease and
treatment, is a limitation of this study. But the finding
that time on dialysis did not differ between survivors
and non-survivors offsets this limitation, so that it does
not preclude the hypothesis that the stage of treatment
Table 1 Comparison of demographic and clinical variables between survivors and non-survivors
Variables Survivors Non-survivors Full sample P
Sex
Male 84 (60.0) 14 (66.6) 98 (60.9) 0.637
Female 56 (40.0) 7 (33.4) 63 (39.1)
Age 43.1 ± 15.7 53.6 ± 11.9 44.5 ± 15.6 0.002
Socioeconomic status
a
B 4 (2.9) 3 (14.3) 7 (4.3)
C 33 (23.6) 5 (23.8) 38 (23.6)
D 81 (57.9) 13 (61.9) 94 (58.4)
E 22 (15.7) 0 22 (13.7)
Primary kidney disease
Glomerulonephritis 64 (45.7) 5 (23.8) 69 (42.9) 0.063
Hypertension 31 (22.1) 7 (33.4) 38 (23.6) 0.276
Diabetes 12 (8.6) 4 (19.0) 16 (9.9) 0.230
Policystic kidney 9 (6.4) 2 (9.5) 11 (6.8) 0.117
Obstructive uropathy 6 (4.2) 1 (4.8) 7 (4.3) 1.000
Lupus 4 (2.9) 0 4 (2.5) 1.000
Chronic pyelonephritis 4 (2.9) 0 4 (2.5) 0.658
Indeterminate 10 (7.2) 2 (9.5) 12 (7.5) 1.000
Time on dialysis (months) 55.4 ± 52.8 50.9 ± 39.5 54.8 ± 51.2 0.989
Comorbidity
b
Low 115 (82.2) 11 (52.4) 126 (78.3) 0.002
Medium 22 (15.7) 6 (28.6) 28 (17.4)
High 3 (2.1) 4 (19.0) 7 (4.3)
Included on transplant waiting list 80 (57.1) 5 (23.8) 85 (52.7) 0.005
Laboratory tests
Creatinine (mg/dl) 12.7 ± 3.6 11.8 ± 4.0 12.6 ± 3.6 0.140
Hemoglobin (g/dl) 8.5 ± 1.7 8.2 ± 1.6 8.5 ± 1.7 0.665
Albumin (g/dl) 4.3 ± 0.4 4.4 ± 0.5 4.3 ± 0.4 0.567
Calcium-phosphorus product (mg
2/dl
2) 46.2 ± 13.0 49.6 ± 15.6 46.6 ± 13.4 0.476
Kt/V index 1.5 ± 0.5 1.6 ± 0.5 1.5 ± 0.5 0.807
Data are means ± SD, or percentages (in parentheses)
aBrazilian Association of Research Institutes, B (best status) and E (worst status)
bKhan index
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than physical status. And above all, the method usually
used in dialysis studies about mortality is the same as
that presented here: yearly crude mortality rate consid-
ering prevalent patients. Moreover, patients with fewer
than three months on treatment were excluded to avoid
confusion of clinical instability and poor physical status,
typical of incidental patients undergoing HD. Another
important limitation is the small size of the sample and
low number of deaths. The reason is that the study
comprised patients from a single renal unit. But we
must highlight that this renal unit is the only one cover-
ing a wide region and the only place where end-stage
renal disease patients are treated in that region, so the
data have the potential to validate the sample as charac-
teristic of northeastern Brazil.
Conclusions
The variables that were able to indicate risk of death
were all related to physical status, like age, comorbidity
grade and the condition of not being on the transplant
waiting list. The only of quality of life dimension–a pos-
sible subjective indicator–that was correlated with death
was physical functioning, which reflects physical status
more than subjective feelings.
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